Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$1.7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$279M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| ANDO GORAN | Aug 21, 2024 | Buy | 5,000 | $7.95 | $40,000 |
| DICICCO WENDY F | Aug 20, 2024 | Buy | 2,567 | $7.79 | $20,000 |
| Zaderej Karen L. | Aug 19, 2024 | Buy | 12,500 | $7.98 | $100,000 |
| Lurker Nancy | Aug 16, 2024 | Buy | 3,173 | $7.88 | $25,000 |
| GUYER DAVID R | Jul 12, 2024 | Sell | 11,625 | $10.0641 | $120,000 |
| GUYER DAVID R | Jun 3, 2024 | Sell | 11,625 | $10.2972 | $120,000 |
| GUYER DAVID R | May 14, 2024 | Sell | 11,625 | $12.649 | $150,000 |
| Cormorant Asset Management, LP | May 6, 2024 | Buy | 642,847 | $11.7 | $7.5M |
| Cormorant Asset Management, LP | May 6, 2024 | Buy | 207,153 | $12.36 | $2.6M |
| Cormorant Asset Management, LP | Apr 18, 2024 | Buy | 395,244 | $17.62 | $7M |
| Cormorant Asset Management, LP | Apr 18, 2024 | Buy | 186,521 | $18.9 | $3.5M |
| Jones David Scott | Feb 2, 2024 | Sell | 209 | $28.49 | $6,000 |
| Paggiarino Dario A. | Jan 26, 2024 | Sell | 33,665 | $25.7737 | $870,000 |
| Paggiarino Dario A. | Jan 26, 2024 | Sell | 15,609 | $25.4066 | $400,000 |
| Jones David Scott | Jan 26, 2024 | Sell | 16,413 | $25.4465 | $420,000 |
| Jones David Scott | Jan 26, 2024 | Sell | 9,604 | $25.2725 | $240,000 |
| Paggiarino Dario A. | Jan 26, 2024 | Sell | 51 | $25.4066 | $1,300 |
| Paggiarino Dario A. | Jan 25, 2024 | Sell | 300 | $25 | $7,500 |
| Jones David Scott | Jan 25, 2024 | Sell | 300 | $25 | $7,500 |
| Lurker Nancy | Jan 24, 2024 | Sell | 29,956 | $24.9783 | $750,000 |
| Jones David Scott | Jan 24, 2024 | Sell | 5,700 | $25.0094 | $140,000 |
| Jones David Scott | Jan 24, 2024 | Sell | 5,600 | $25.0121 | $140,000 |
| Paggiarino Dario A. | Jan 24, 2024 | Sell | 5,651 | $25.0156 | $140,000 |
| Paggiarino Dario A. | Jan 24, 2024 | Sell | 5,600 | $25.0093 | $140,000 |
| Paggiarino Dario A. | Jan 23, 2024 | Sell | 3,096 | $25 | $77,000 |
| Paggiarino Dario A. | Jan 23, 2024 | Sell | 2,039 | $25 | $51,000 |
| Lurker Nancy | Jan 23, 2024 | Sell | 5,044 | $24.9702 | $130,000 |
| Jones David Scott | Jan 23, 2024 | Sell | 500 | $25 | $13,000 |
| Jones David Scott | Jan 23, 2024 | Sell | 400 | $25 | $10,000 |
| Jones David Scott | Jan 22, 2024 | Sell | 28,750 | $22.6871 | $650,000 |
| Jones David Scott | Jan 22, 2024 | Sell | 5,416 | $22.2373 | $120,000 |
| Ocumension Therapeutics | Jan 11, 2024 | Sell | 1,910,500 | $19.45 | $37M |
| Liu Ye | Jan 11, 2024 | Sell | 1,910,500 | $19.45 | $37M |
| Cormorant Asset Management, LP | Jan 11, 2024 | Buy | 750,000 | $19.75 | $15M |
| Cormorant Asset Management, LP | Jan 9, 2024 | Buy | 105,000 | $21.32 | $2.2M |
| Paggiarino Dario A. | Jan 8, 2024 | Sell | 22,913 | $21.1288 | $480,000 |
| Paggiarino Dario A. | Dec 13, 2023 | Sell | 1,458 | $20 | $29,000 |
| Cormorant Asset Management, LP | Dec 8, 2023 | Buy | 588,235 | $17 | $10M |
| Ocumension Therapeutics | Dec 6, 2023 | Sell | 266,242 | $18.41 | $4.9M |
| Liu Ye | Dec 6, 2023 | Sell | 266,242 | $18.41 | $4.9M |
| Ocumension Therapeutics | Dec 5, 2023 | Sell | 733,758 | $19.91 | $15M |
| Liu Ye | Dec 5, 2023 | Sell | 733,758 | $19.91 | $15M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 945,664 | $19.88 | $19M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 321,259 | $18.8 | $6M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 122,625 | $20.62 | $2.5M |
| Pine Michael Craig | Dec 4, 2023 | Sell | 45,000 | $22 | $990,000 |
| Pine Michael Craig | Dec 4, 2023 | Sell | 45,000 | $22 | $990,000 |
| Paggiarino Dario A. | Dec 4, 2023 | Sell | 30,625 | $22 | $670,000 |
| Lurker Nancy | Dec 4, 2023 | Sell | 20,000 | $20.76 | $420,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 86,713 | $31.83 | $2.8M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 79,805 | $21.87 | $1.7M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 65,086 | $25.88 | $1.7M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 53,109 | $26.73 | $1.4M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 41,824 | $33.08 | $1.4M |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 39,899 | $24.87 | $990,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 37,081 | $24.01 | $890,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 28,090 | $22.8 | $640,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 27,425 | $27.87 | $760,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 19,866 | $33.75 | $670,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 18,601 | $29.91 | $560,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 15,582 | $30.74 | $480,000 |
| Pine Michael Craig | Dec 4, 2023 | Sell | 1,000 | $20.79 | $21,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 8,260 | $34.49 | $280,000 |
| Cormorant Asset Management, LP | Dec 4, 2023 | Buy | 8,168 | $28.78 | $240,000 |
| Essex Woodlands Fund IX-GP, L.P. | Sep 1, 2023 | Sell | 20,000 | $9.8991 | $200,000 |
| Essex Woodlands Fund IX-GP, L.P. | Sep 1, 2023 | Sell | 20,000 | $9.8991 | $200,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 31, 2023 | Sell | 71,478 | $10.1671 | $730,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 31, 2023 | Sell | 7,017 | $11.0214 | $77,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 30, 2023 | Sell | 60,649 | $10.9224 | $660,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 30, 2023 | Sell | 327 | $11.3595 | $3,700 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 29, 2023 | Sell | 87,289 | $10.7424 | $940,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 29, 2023 | Sell | 565 | $11.56 | $6,500 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 28, 2023 | Sell | 60,858 | $11.7101 | $710,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 25, 2023 | Sell | 54,656 | $11.1854 | $610,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 25, 2023 | Sell | 30,000 | $10.671 | $320,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 25, 2023 | Sell | 72,925 | $11.09 | $810,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 25, 2023 | Sell | 11,731 | $10.45 | $120,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 24, 2023 | Sell | 139,280 | $14.6187 | $2M |
| Essex Woodlands Fund IX-GP, L.P. | Aug 24, 2023 | Sell | 87,100 | $11.54 | $1M |
| Essex Woodlands Fund IX-GP, L.P. | Aug 24, 2023 | Sell | 52,180 | $10.56 | $550,000 |
| Essex Woodlands Fund IX-GP, L.P. | Aug 23, 2023 | Sell | 121,103 | $13.0543 | $1.6M |
| Essex Woodlands Fund IX-GP, L.P. | Aug 22, 2023 | Sell | 46,778 | $14.6187 | $680,000 |
| Liu Ye | May 30, 2023 | Sell | 1 | $6 | $6 |
What's the latest insider transaction for Eyepoint Pharmaceuticals?
The most recent insider transaction for Eyepoint Pharmaceuticals was conducted by ANDO GORAN, who sold 5,000 shares on August 21, 2024 at a price of $7.95 per share.
Which insider bought the most EYPT stock over the last two years?
Cormorant Asset Management, LP has bought the most EYPT stock in the last 2 years, with a total value of $89M.
Which insider has sold the most EYPT stock over the last two years?
Liu Ye has sold the most EYPT stock in the last 2 years, with a total value of $57M.
What is the total value of insider transactions for Eyepoint Pharmaceuticals (EYPT) in the last 2 years?
The total value of insider transactions for Eyepoint Pharmaceuticals in the last 2 years is negative, amounting to -$43M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Eyepoint Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Eyepoint Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
